OBJECTIVE: To measure muscle strength in patients with spinal muscular atrophy using a handheld dynamometer as an objective tool to evaluate the progression of disease and the outcome of therapeutic trials. DESIGN: Maximum voluntary isometric contraction was measured in a group of 24 patients aged 5-38 years with types II and III spinal muscular atrophy. Four muscle groups were examined. Data were grouped according to age and sex. Comparison was made between spinal muscular atrophy types; ambulatory vs non-ambulatory, and survival motor neuron (SMN)2 copies. The results were compared with those of a healthy reference population. RESULTS: Muscle strength was much lower in patients with spinal muscular atrophy than in the healthy population. The walkers group yielded higher values than patients who were non-walkers. Knee extensors were the weakest muscles in both groups, regardless of the ability to walk. The greatest differences were found between ambulatory and non-ambulatory patients. Non-walkers type III patients showed lower values, similar to those for type II patients. Patients with 3 and 4 SMN2 copies showed higher strength with respect to those with 2 SMN2 copies, although not statistically significant. CONCLUSION: The handheld dynamometer is a valid tool for measuring muscle strength in patients with spinal muscular atrophy. It can be used to measure disease progression and to evaluate changes in therapeutic trials.
OBJECTIVE: To measure muscle strength in patients with spinal muscular atrophy using a handheld dynamometer as an objective tool to evaluate the progression of disease and the outcome of therapeutic trials. DESIGN: Maximum voluntary isometric contraction was measured in a group of 24 patients aged 5-38 years with types II and III spinal muscular atrophy. Four muscle groups were examined. Data were grouped according to age and sex. Comparison was made between spinal muscular atrophy types; ambulatory vs non-ambulatory, and survival motor neuron (SMN)2 copies. The results were compared with those of a healthy reference population. RESULTS: Muscle strength was much lower in patients with spinal muscular atrophy than in the healthy population. The walkers group yielded higher values than patients who were non-walkers. Knee extensors were the weakest muscles in both groups, regardless of the ability to walk. The greatest differences were found between ambulatory and non-ambulatory patients. Non-walkers type III patients showed lower values, similar to those for type II patients. Patients with 3 and 4 SMN2 copies showed higher strength with respect to those with 2 SMN2 copies, although not statistically significant. CONCLUSION: The handheld dynamometer is a valid tool for measuring muscle strength in patients with spinal muscular atrophy. It can be used to measure disease progression and to evaluate changes in therapeutic trials.
Authors: Megan E Slater; Julia Steinberger; Julie A Ross; Aaron S Kelly; Eric J Chow; Ildiko H Koves; Paul Hoffmeister; Alan R Sinaiko; Anna Petryk; Antoinette Moran; Jill Lee; Lisa S Chow; K Scott Baker Journal: Biol Blood Marrow Transplant Date: 2015-04-10 Impact factor: 5.742
Authors: Aga Lewelt; Kristin J Krosschell; Gregory J Stoddard; Cindy Weng; Mei Xue; Robin L Marcus; Eduard Gappmaier; Louis Viollet; Barbara A Johnson; Andrea T White; Donata Viazzo-Trussell; Philippe Lopes; Robert H Lane; John C Carey; Kathryn J Swoboda Journal: Muscle Nerve Date: 2015-10 Impact factor: 3.217
Authors: C Cumplido-Trasmonte; J Ramos-Rojas; E Delgado-Castillejo; E Garcés-Castellote; G Puyuelo-Quintana; M A Destarac-Eguizabal; E Barquín-Santos; A Plaza-Flores; M Hernández-Melero; A Gutiérrez-Ayala; M Martínez-Moreno; E García-Armada Journal: J Neuroeng Rehabil Date: 2022-07-19 Impact factor: 5.208
Authors: Petra Kaufmann; Michael P McDermott; Basil T Darras; Richard S Finkel; Douglas M Sproule; Peter B Kang; Maryam Oskoui; Andrei Constantinescu; Clifton L Gooch; A Reghan Foley; Michele L Yang; Rabi Tawil; Wendy K Chung; William B Martens; Jacqueline Montes; Vanessa Battista; Jessica O'Hagen; Sally Dunaway; Jean Flickinger; Janet Quigley; Susan Riley; Allan M Glanzman; Maryjane Benton; Patricia A Ryan; Mark Punyanitya; Megan J Montgomery; Jonathan Marra; Benjamin Koo; Darryl C De Vivo Journal: Neurology Date: 2012-10-17 Impact factor: 9.910
Authors: Zohar Argov; Faye Bronstein; Alicia Esposito; Yael Feinsod-Meiri; Julaine M Florence; Eileen Fowler; Marcia B Greenberg; Elizabeth C Malkus; Odelia Rebibo; Catherine S Siener; Yoseph Caraco; Edwin H Kolodny; Heather A Lau; Alan Pestronk; Perry Shieh; Alison M Skrinar; Jill E Mayhew Journal: J Clin Neuromuscul Dis Date: 2017-09
Authors: Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Nadine A Kasparian; Michelle A Farrar Journal: Orphanet J Rare Dis Date: 2019-04-02 Impact factor: 4.123
Authors: Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar Journal: Orphanet J Rare Dis Date: 2020-03-12 Impact factor: 4.123